Australia Sepsis Diagnostics Market Size & Outlook
- Clinical Diagnostics
- In Vitro Diagnostics
- Sepsis Diagnostics Market Outlook
- In Vitro Diagnostics
Global Market
Related Markets
Ask Prism AI about the sepsis diagnostics market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Australia sepsis diagnostics market highlights
- The Australia sepsis diagnostics market generated a revenue of USD 22.0 million in 2025 and is expected to reach USD 53.8 million by 2033.
- The Australia market is expected to grow at a CAGR of 11.9% from 2026 to 2033.
- In terms of segment, conventional diagnostics was the largest revenue generating method in 2025.
- Automated Diagnostics is the most lucrative method segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2025 | USD 22.0 million |
| Market revenue in 2033 | USD 53.8 million |
| Growth rate | 11.9% (CAGR from 2026 to 2033) |
| Largest segment | Conventional diagnostics |
| Fastest growing segment | Automated Diagnostics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Automated Diagnostics, Conventional Diagnostics |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, Australia accounted for 1.8% of the global sepsis diagnostics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, Japan sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 99.3 million by 2033.
The sepsis diagnostics market in Australia is expected to witness significant growth, driven by several crucial factors that highlight the increasing importance of early detection and effective management of this life-threatening condition.
According to estimates from the 2021 Australian Commission on Safety and Quality in Health Care, sepsis is a major concern within the Australian healthcare system, with over 48,000 hospital admissions annually where sepsis is the primary diagnosis.
In addition, sepsis is responsible for around 1,400 deaths annually, highlighting its severe impact on patient outcomes. These figures underscore the critical need for effective diagnostic tools and interventions to improve early detection & treatment, aiming to reduce the incidence & mortality associated with this life threatening condition.
No credit card required*
Publish Date: Jun 10, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Koninklijke Philips NV | View profile | 73,712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | www.philips.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Bruker Corp | View profile | 9,707 | 40 Manning Road, Billerica, MA, United States, 01821 | www.bruker.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Luminex | View profile | 501-1000 | Austin, Texas, United States, North America | www.luminexcorp.com |
| Cepheid | View profile | 1001-5000 | Sunnyvale, California, United States, North America | www.cepheid.com |
| Immunexpress | View profile | 11-50 | Seattle, Washington, United States, North America | www.immunexpress.com |
Australia Sepsis Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Sepsis Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Conventional Diagnostics was the largest segment with a revenue share of 64.55% in 2025.
Horizon Databook has segmented the Australia sepsis diagnostics market based on automated diagnostics, conventional diagnostics covering the revenue growth of each sub-segment from 2021 to 2033.
The sepsis diagnostics market in Australia is expected to witness significant growth, driven by several crucial factors that highlight the increasing importance of early detection and effective management of this life-threatening condition.
According to estimates from the 2021 Australian Commission on Safety and Quality in Health Care, sepsis is a major concern within the Australian healthcare system, with over 48,000 hospital admissions annually where sepsis is the primary diagnosis.
In addition, sepsis is responsible for around 1,400 deaths annually, highlighting its severe impact on patient outcomes. These figures underscore the critical need for effective diagnostic tools and interventions to improve early detection & treatment, aiming to reduce the incidence & mortality associated with this life threatening condition.
- Australia Sepsis Diagnostics Market Method Outlook (Revenue, USD Million , 2021-2033)
- Automated Diagnostics
- Conventional Diagnostics
- Australia Sepsis Diagnostics Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Immunoassays
- Others
- Microbiology
- Flow Cytometry
- Molecular Diagnostics
- Australia Sepsis Diagnostics Market Pathogen Outlook (Revenue, USD Million , 2021-2033)
- Bacterial Sepsis
- Fungal Sepsis
- Viral Sepsis and Others
- Australia Sepsis Diagnostics Market Testing Type Outlook (Revenue, USD Million , 2021-2033)
- Laboratory Testing
- Point-of-Care Testing
- Australia Sepsis Diagnostics Market End User Outlook (Revenue, USD Million , 2021-2033)
- Hospitals & Clinics
- Pathology & Reference Laboratories
- Research Institutes and Others
- Australia Sepsis Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Blood Culture Media
- Assay Kits & Reagents
- Software
Reasons to subscribe to Sepsis Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Sepsis Diagnostics Market Outlook databook
- Our clientele includes a mix of Sepsis Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Sepsis Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Sepsis Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Australia Sepsis Diagnostics Market, 2021-2033 (US$M)
Australia sepsis diagnostics market statistics, by method, 2021-2033 (US$M)
